Jeffrey Guss, MD

Jeffrey Guss, MD, is a psychiatrist, psychoanalyst, researcher and teacher with specializations in psychoanalytic therapy and psychedelic therapy. He is on the faculty of the NYU Postdoctoral Program in Psychotherapy and Psychoanalysis and is a Clinical Assistant Professor of Psychiatry at NYU School of Medicine.

Dr. Guss was the Co-Principal Investigator and Director of Psychedelic Therapy Training for the NYU study on psilocybin-assisted psychotherapy in the treatment of cancer anxiety and is a study therapist with several MAPS studies. He has published on the integration of Acceptance and Commitment Therapy with psychedelic assisted therapy for MDD in Journal of Contextual and Behavioral Science and co-authored a paper on the influence of therapists’ firsthand psychedelic experiences. He maintains a private practice in New York City.

Speaker Disclosures:
Financial: Dr. Jeffrey Guss is a lead trainer with Fluence. He has employment relationships with California Institute for Integral Studies, Yale University, and Cybin. Dr. Guss maintains a private practice. He receives a speaking honorarium from PESI, Inc.
Non-financial: Dr. Jeffrey Guss is a study therapist with the New York University Medical Center Research and is a sub-investigator in MAPS.